Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marie Bartoušková"'
Autor:
David Vrána, Marcel Matzenauer, Čestmír Neoral, René Aujeský, Radek Vrba, Bohuslav Melichar, Nikol Rušarová, Marie Bartoušková, Janusz Jankowski
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 1, p 13 (2018)
Esophageal and gastric cancers represent tumors with poor prognosis. Unfortunately, radiotherapy, chemotherapy, and targeted therapy have made only limited progress in recent years in improving the generally disappointing outcome. Immunotherapy with
Externí odkaz:
https://doaj.org/article/1611c5c5ae59434586d9f390be773f16
Autor:
Rastislav Slavkovský, Jana Stránská, Veronika Věnsková, Sylwia Jančik, Lucie Kotková, Jarmila Šimová, Petr Vojta, Patrik Flodr, Marie Bartoušková, Hana Študentová, Marián Hajdúch, Jiří Drábek
Publikováno v:
Neoplasma. 69:203-215
The presence of wild-type RAS alleles, as determined by genotyping codons 12, 13, 59, 61, 117, and 146, is a prerequisite for personalized anti-EGFR treatment of metastatic colorectal cancer (mCRC) patients. Here we describe analytical validation of
Autor:
Kateřina Kučerová, Hana Študentová, Bohuslav Melichar, Michaela Hrouzková, Pavla Petrová, Andrea Vernerová, Filip Čtvrtlík, Nikol Rušarová, Marie Bartoušková
Publikováno v:
Pteridines, Vol 31, Iss 1, Pp 151-157 (2020)
In patients with metastatic melanoma the advent of targeted therapy and immune checkpoint inhibitors has transformed the management of advanced and metastatic disease, resulting in improved outcomes. Neopterin is a biomarker of immune activation incr
Publikováno v:
Onkologie. 13:37-42
Autor:
Bohuslav Melichar, Marie Bartoušková
Publikováno v:
Clinical chemistry and laboratory medicine. 58(9)
During the past 20 years, targeted therapy based on the understanding of tumor biology has been complementing or even replacing cytotoxic agents that have dominated pharmacotherapy of cancer since the conception of medical oncology. Unfortunately, th
Autor:
Lenka Javorská, Hana Študentová, Lenka Kujovská Krčmová, Denisa Vitásková, Dagmar Solichová, Radomír Hyšpler, Bohuslav Melichar, Eliška Pešková, Klára Hrůzová, Marie Bartoušková
Publikováno v:
Pteridines, Vol 28, Iss 3-4, Pp 213-220 (2017)
In the present study, we determined complex indices of inflammatory activity and compared the performance of these indices as prognostic biomarkers in a cohort of breast cancer patients. All proposed composite biomarkers could be evaluated in 418 out
Autor:
Lenka Javorská, Marie Bartoušková, Hana Študentová, Dagmar Solichová, Klára Hrůzová, Bohuslav Melichar, Milan Vošmik, Dušan Klos, Radomír Hyšpler, Eliška Pešková, Eva Malířová, Lenka Kujovská Krčmová
Publikováno v:
Pteridines, Vol 28, Iss 3-4, Pp 221-232 (2017)
The aim of the present study was to investigate the association of peripheral-blood cell count (PBC)-derived ratios, other biomarkers of inflammation and biomarkers of tumor growth with outcome in a cohort of patients presenting for the next line of
Autor:
Jarmila Juráňová, Lenka Kujovská Krčmová, Jana Janková, Denisa Vitásková, Hana Študentová, Dušan Klos, Marie Bartoušková, Tomáš Adam, David Vrána, Nora Zlamalova, Lenka Javorská, Bohuslav Melichar, Zuzana Vlachová
Publikováno v:
Pteridines, Vol 28, Iss 3-4, Pp 233-241 (2017)
We report a patient who presented with synchronous second primary human epidermal growth factor receptor (HER)-2-positive breast cancer and rectal cancer that both required simultaneous neoadjuvant therapy. A modified regimen combining anti-HER-2 mon
Autor:
Marie Bartoušková, Lucie Sedláčková, Nikol Rušarová, O. Kalita, Lumir Hrabalek, Marcel Matzenauer, Lucie Tučková, David Vrána
Publikováno v:
Klinicka Onkologie. 32
BACKGROUND Primary intracranial sarcoma is a rare disease. Due to the scarcity of evidence from randomized clinical trials, we follow the treatment guidelines of their extracranial counterparts or those published in case reports, while taking into co
Publikováno v:
Pteridines, Vol 26, Iss 1, Pp 1-12 (2015)
Ovarian cancer is the most frequent cause of gynecological cancer-related death. Unfortunately, many patients are diagnosed at an advanced stage and have a poor prognosis. The standard treatment for advanced disease involves maximal cytoreductive sur